Twist Bioscience Corp (TWST) stock is currently valued at $30.21. During the last session, the stock experienced a remarkable rise, reaching $62.0 after opening at $30.21. The stock briefly dropped to $33.0 before ultimately closing at $33.68.
The market performance of Twist Bioscience Corp’s stock has been turbulent in recent times.
52-week price history of TWST Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Twist Bioscience Corp’s current trading price is -45.40% away from its 52-week high, while its distance from the 52-week low is 11.39%. The stock’s price range during the 52-week period has remained between $27.12 and $55.33. In the Healthcare sector, the company’s shares saw a trading volume of around 4.9 million for the day, which was evidently higher than the average daily volume of 1.11 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Twist Bioscience Corp (TWST) has experienced a quarterly decline of -23.01% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.81B and boasts a workforce of 923 employees.
A Closer Look at Analysts’ Ratings for Twist Bioscience Corp
As of right now, 6 analysts are rating Twist Bioscience Corp as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 35.86, with a change in price of -8.92. Similarly, Twist Bioscience Corp recorded 1,160,175 in trading volume during the last 100 days, posting a change of -22.80%.
Examining TWST’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for TWST stands at 0.16. Similarly, the long-term debt-to-equity ratio is also 0.13.
TWST Stock Stochastic Average
As of today, Twist Bioscience Corp’s raw stochastic average for the last 50 days stands at 25.22%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 22.70%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 14.50% and 10.95%, respectively.
TWST Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -45.87%. However, over the last six months, the performance has been stronger by -42.31%. The price of TWST decreased -20.85% over the last 30 days. And in the last five days, it has fallen by -17.30%.
